Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
JAMA|February 9, 2000
Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutationsD Schrag, K M Kuntz, J E Garber, et al.The New England Journal of Medicine|May 15, 1997
Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutationsD Schrag, K M Kuntz, J E Garber, et al.Annals of Internal Medicine|December 5, 1998
Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutationsS Syngal, J C Weeks, D Schrag, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.JAMA|August 11, 2000
Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polypsS Syngal, D Schrag, M Falchuk, et al.Hematology/Oncology Clinics of North America|June 1, 1994
Markers of risk for human malignanciesJ E GarberSeminars in Oncology|October 21, 1999
Costs and cost-effectiveness of colorectal cancer prevention and therapyD Schrag, J WeeksCurrent Opinion in Pediatrics|December 1, 1993
Screening children at genetic risk of cancerJ E Garber, L DillerSeminars in Oncology|August 11, 2001
Genetic susceptibility for breast cancer--risk assessment and counselingP Ang, J E GarberJournal of the National Cancer Institute. Monographs|January 1, 1995
Testing and counseling adults for heritable cancer riskB B Biesecker, J E GarberPageof 15